Subscribe
shutterstock_1826477633_hjbc
HJBC / Shutterstock.com
2 August 2022MedtechStaff Writer

Medtech firm faces lawsuit over COVID–19 design

Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Vaccine makers hit back against patent claims
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Medtech
Medtech firm takes ex-employee to court over alleged trade secrets breach
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Medtech
Medtech firm takes ex-employee to court over alleged trade secrets breach
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Big Pharma
Vaccine makers hit back against patent claims
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.

More on this story

Medtech
Medtech firm takes ex-employee to court over alleged trade secrets breach
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Big Pharma
Vaccine makers hit back against patent claims
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility